Skip to main content

Surrogate Endpoint

  • Reference work entry
  • First Online:
Encyclopedia of Cancer

Synonyms

Intermediate endpoint; Surrogate endpoint biomarker; Surrogate outcome

Definition

A surrogate endpoint is an outcome observed prior to a health outcome of interest (called the true endpoint) that is used to make conclusions about the effect of intervention on the true endpoint.

Characteristics

Role of Surrogate Endpoints in Cancer Research

The role of surrogate endpoints in cancer research depends on the purposes of the analysis. The main roles are to

  • Shorten the length of time needed to evaluate a new treatment for clinical use.

  • Quickly and cheaply evaluate interventions at an early phase of development as a prelude to more rigorous evaluation.

Ideally, these roles require the surrogate endpoint to be validated. As with so many terms used in the medical literature, the meaning of the term “validation” can vary among medical scientists. We define validation of a surrogate endpoint as a formal process of data analysis for determining how well the surrogate endpoint can be used...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 2,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Baker SG (2006) Surrogate endpoints: wishful thinking or reality. J Natl Cancer Inst 98:502–503

    Article  PubMed  Google Scholar 

  2. Johnson KR, Ringlard C, Stokes BJ et al (2006) Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis. Lancet Oncol 7:741–746

    Article  PubMed  Google Scholar 

  3. Lassere MN, Johnson KR, Boers M et al (2007) Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schema. J Rheumatol Journal of pheumatology 34(3):607–615

    Google Scholar 

  4. Sargent DJ, Wieand HJ, Haller DG et al (2005) Disease-free survival versus overall survival as a primary endpoint for adjuvant colon cancer studies: individual patient data form 20,898 patients on 18 randomized trials. J Clin Oncol 23:8664–8670

    Article  PubMed  Google Scholar 

  5. Weir CJ, Walley RJ (2006) Statistical evaluation of biomarkers as surrogate endpoints: a literature review. Stat Med 25:83–203

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stuart G. Baker .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Baker, S.G., Kramer, B.S. (2011). Surrogate Endpoint. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16483-5_5602

Download citation

Publish with us

Policies and ethics